Diagnosis and management of thyroid eye disease

被引：5

作者：

Denniston, A ^{[1
]}

Dodson, P ^{[1
]}

Reuser, T ^{[1
]}

机构：

[1] Birmingham Heartlands Hosp, Dept Ophthalmol, Birmingham B9 5SS, W Midlands, England

来源：

HOSPITAL MEDICINE | 2002年 / 63卷 / 03期

关键词：

D O I：

10.12968/hosp.2002.63.3.2060

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent advances are helping elucidate the pathogenesis and improve the management of thyroid eye disease. While biochemical investigations and imaging may be supportive, ophthalmological and medical clinical assessments remain the key to the diagnosis and management of this sight-threatening disorder.

引用

页码：152 / 156

页数：5

共 17 条

[1]

BAHN RS, 1993, NEW ENGL J MED, V329, P1468

[2] Management of Graves' ophthalmopathy: Reality and perspectives [J].

Bartalena, L ;

Pinchera, A ;

Marcocci, C .

ENDOCRINE REVIEWS, 2000, 21 (02) :168-199

[3] Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy [J].

Bartalena, L ;

Marcocci, C ;

Bogazzi, F ;

Manetti, L ;

Tanda, ML ;

Dell'Unto, E ;

Bruno-Bossio, G ;

Nardi, M ;

Bartolomei, MP ;

Lepri, A ;

Rossi, G ;

Martino, E ;

Pinchera, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :73-78

[4]

Bartley G B, 1994, Trans Am Ophthalmol Soc, V92, P477

[5] Thyroid eye disease [J].

Char, DH .

BRITISH JOURNAL OF OPHTHALMOLOGY, 1996, 80 (10) :922-926

[6] Genetic determinants of Graves disease [J].

Chistyakov, DA ;

Savost'anov, KV ;

Turakulov, RI ;

Nosikov, VV .

MOLECULAR GENETICS AND METABOLISM, 2000, 71 (1-2) :66-69

[7] Quality of life in patients with Graves' ophthalmopathy is markedly decreased: Measurement by the medical outcomes study instrument [J].

Gerding, MN ;

Terwee, CB ;

Dekker, FW ;

Koornneef, L ;

Prummel, MF ;

Wiersinga, WM .

THYROID, 1997, 7 (06) :885-889

[8]

Heufelder A E, 2000, Strabismus, V8, P101, DOI 10.1076/0927-3972(200006)8:2

[9]

1-2

[10]

FT101

← 1 2 →